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Background: Past studies of relationships between alcohol and hip fracture have generally focused on total alcohol
consumed and not type of alcohol. Different types of alcohol consist of varying components which may affect risk
of hip fracture differentially. This study seeks to examine the relationship between alcohol consumption, with a
focus on type of alcohol consumed (e.g. beer, wine, or hard liquor) and hip fracture risk in post-menopausal
women.
Methods: The longitudinal cohort consisted of U.S. post-menopausal women aged 50–79 years enrolled between
1993–1998 in the Women’s Health Initiative Clinical Trials and Observational Study (N=115,655).
Results: Women were categorized as non-drinkers, past drinkers, infrequent drinkers and drinkers by preference of
alcohol type (i.e. those who preferred wine, beer, hard liquor, or who had no strong preference). Mean alcohol
consumption among current drinkers was 3.3 servings per week; this was similar among those who preferred wine,
beer and liquor. After adjustment for potential confounders, alcohol preference was strongly correlated with hip
fracture risk (p = 0.0167); in particular, women who preferred wine were at lower risk than non-drinkers (OR=0.78;
95% CI 0.64-0.95), past drinkers (OR=0.85; 95% CI 0.72-1.00), infrequent drinkers (OR=0.73; 95% CI 0.61-0.88), hard
liquor drinkers (OR=0.87; 95% CI 0.71-1.06), beer drinkers (OR=0.72; 95% CI 0.55-0.95) and those with no strong
preference (OR=0.89; 95% CI 0.89; 95% CI 0.73-1.10).
Conclusions: Preference of alcohol type was associated with hip fracture; women who preferentially consumed
wine had a lower risk of hip fracture compared to non-drinkers, past drinkers, and those with other alcohol
preferences.
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Hip fractures are a major public health problem world-
wide [1], contributing to decreased quality of life and pre-
mature death [1-6]. In the United States, over 280,000
people over the age of 65 experienced a hip fracture in
2007 [5]. In 2005, the estimated total cost of hip fractures
in the US was $12 billion and was estimated to increase
50% by 2025 [7]. More than two-thirds of all hip fractures
occur in women [5,8] and older age significantly increases
the risk of fracture [5,9,10] with those 85 and older having
a ten-fold risk compared to those who are 60–65 [5].* Correspondence: jkubo@stanford.edu
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reproduction in any medium, provided the orOther factors known to be associated with hip fracture in-
cidence include low body mass index [11], European or
Asian race/ethnicity [12,13], smoking [14,15] and less
physical activity [2,13,16]. A previous analysis of Women’s
Health Initiative (WHI) Observational Study (OS) data
identified each of these factors as important predictors of
hip fracture [17].
Light-to-moderate alcohol consumption has been shown
to be associated with reduced risk of hip fracture and in-
creased bone density [18-22]. More precisely, a U-shaped
relationship has been observed in which non-drinkers
and heavy drinkers have an elevated risk of hip fracture
compared to light-moderate drinkers. The 2010 Dietary
Guidelines for Americans defines moderate alcohol con-
sumption as up to one drink per day for women [23].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tion may be related to hip fracture, the risk of hip frac-
ture may be different for those who consume beer, wine,
and hard liquor as was observed for cardiovascular dis-
ease [24,25] and overall mortality [24-28]. In a study of
31,785 men and women in Denmark, Høidrup et al. [19]
assessed preference of alcohol type among current alco-
hol consumers and found that those who preferred wine
had a reduced risk of hip fracture compared to those
who preferred beer or liquor. In contrast, in their ana-
lysis of the Cardiovascular Health Study, Mukamal et al.
[20] found that the reported consumption of beer, wine
and hard liquor did not have a significant association
with hazard of hip fracture. The discrepancy may be due
to differences in the populations studied; Høidrup et al.
studied Danish adults and Mukamal studied US adults
over 65 from four communities. Another possible reason
for the discrepancy may lie in how the exposure variable
was defined. Whereas Høidrup et al. modeled alcohol
preference, Mukamal et al. modeled consumption of type
using indicator variables. Our study seeks to reconcile in-
consistencies in past studies of alcohol preference and to
take past drinkers and non-drinkers into account. We will
investigate the relationship between type of alcohol con-
sumed and the risk of hip fracture in a large, ethnically
and geographically diverse cohort of postmenopausal
women in the United States with available data on poten-
tially important confounders of the relationship including
physical activity and falls.
Methods
The question of interest was addressed using a large
multi-ethnic cohort of postmenopausal women enrolled
in either the Women’s Health Initiative (WHI) Clinical
Trials (CT, N=68,133) or the Observational Study (OS,
N=93,676) at 40 clinical centers across the United States
between 1993 and 1998. The CT enrolled participants
into one or more clinical trial components: the Hormone
Therapy Trials, Dietary Modification Trial, or Calcium/
Vitamin D Trial; those ineligible or unwilling to partici-
pate in the CT were invited to enroll in the OS, which also
enrolled participants directly [29]. Closeout occurred from
2004–2005 for the main study. Study design and eligibility
have been described previously [30]. The analysis was
based on a cohort that included all eligible WHI par-
ticipants in the CT and OS. The study was approved
by Institutional Review Boards at each clinical center.
All participants provided signed informed consent.
Figure 1 describes the derivation of the cohort. Eligible
participants were those with data on alcohol consump-
tion, with no history of cancer, and no evidence of hip
replacement at baseline. Participants were considered in-
eligible if they were missing relevant data collection
forms. There were 142,224 participants eligible for study.Due to missing covariates included in the scientific model,
26,569 were further excluded, yielding a final analytic data
set of N=115,655 (15.2% missing).
Exclusions were largely due to missing data on prior
hip fractures and parental hip fractures, both of which
were not collected on forms for all participants. Under-
lying reasons for missing the latter, therefore, are un-
likely to be related to participant characteristics. Some
systematic differences were observed, however, between
those participants who were excluded due to missing
data (N=26,569) and those included in the analysis
(N=115,655). For example, a higher proportion of white
women were included in the analysis than among those
excluded (83.65% versus 77.25%). Other differences in-
cluded the percentage of falls (68.81% of those who were
included reported no falls, compared to 61.29% of those
who were excluded), and percentage of participants in-
cluded in the OS cohort (57.70% compared to 45.77%).
Rates of incident hip fracture, however, did not differ by
inclusion status.
Covariates
Type of alcohol consumed was measured in two ways. The
first was a categorical variable that captured preference of
type of alcohol. The second consisted of three non-
mutually exclusive indicator variables for whether a spe-
cific type of alcohol was consumed, where the possibilities
included beer, wine, and hard liquor. More specifically, for
the former, seven mutually exclusive categories of alcohol
preference were created; non-drinker, past drinker, and
current drinkers who prefer beer, wine, hard liquor, have
no strong preference, or drink very infrequently, as
determined by food frequency questionnaire (FFQ)
consumption patterns of beer, wine, and hard liquor
at baseline. Current-beer was assigned to those whose
beer consumption constituted 60 or more percent of their
total alcohol consumption. Current-wine and current-
hard liquor preference were defined similarly. Current-no
strong preference was assigned to those who did not have
a predominating type of alcohol. A participant was classi-
fied as current-infrequent if the participant reported
being a current drinker but did not report consump-
tion on their FFQ. The WHI FFQ was validated for alco-
hol consumption using four day food records and four
day diet recalls [31].
Hip fracture
The primary outcome was an indicator for having a hip
fracture during the WHI study period. Hip fractures
were centrally adjudicated at the WHI Bone Density
Center by a physical adjudicator; participants reporting a
hip fracture on the semi-annual (CT) or annual (OS)
medical history update were contacted for additional in-
formation and medical records [32,33].
WHI cohort
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Figure 1 Construction of the analytic cohort. * NMSC: Non-melanoma skin cancer.
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identified by prior analyses of hip fracture in the WHI
and other cohorts as well as for clinically important vari-
ables. Demographic factors included race/ethnicity, age
group and education at screening. Also included was a
diagnosis of osteoporosis, bisphosphonate drug use, pre-
vious hip fracture at age 55 and up, and history of hip
fracture at age 40 and up for either parent from partici-
pant medical history. Baseline risk factors included
smoking status, hormone therapy use, physical activity
in metabolic equivalents per week, BMI category as de-
fined by WHO, and the number of falls the participant
reported in the past year. All covariates were measured
at baseline. We also included indicators for the relevant
trial arms as defined by the WHI.
Statistical analyses
The relationship between alcohol preference (modeled as
a categorical variable) and risk of hip fracture was assessed
using logistic regression methods. An alternative model
that made use of indicators for each type of alcohol
allowed investigation of associations between types of al-
cohol and risk of hip fracture as opposed to preference of
alcohol type. Odds ratios that describe the association are
presented after adjusting for listed confounders. Addition-
ally, several covariates (falls in the past year, BMI, educa-
tion and age) were explored as potential mediators and
moderators of the relationship between alcohol consump-
tion and hip fracture. Total alcohol consumption was also
explored as a confounder.
As the CT and OS populations differ slightly, the two
study cohorts were additionally analyzed separately as a
sensitivity analysis. Data on red and white wine con-
sumption were available in the OS cohort at year 1 of
follow up; to explore differences between red and whitewine those who preferred wine were additionally split
based on whether they reported higher consumption of
red wine, higher consumption of white wine, or equal con-
sumption of red and white wine. Several additional
sensitivity analyses were performed; in the first, par-
ticipants reporting a prior hip fracture at baseline were ex-
cluded from analysis. The second excluded participants
who reported having osteoporosis at baseline. A final sen-
sitivity analysis, for the indicator model, defined alcohol
use for moderate drinkers only (>1 drink/day) in accord-
ance with the 2010 Dietary Guidelines for Americans [23].
All analyses were performed with SAS software, Version
9.3 (SAS Institute Inc., Cary, NC) of the SAS System for
Windows.
Results
Table 1 presents baseline characteristics of the 115,655
women in the analytic cohort. On average they were 63.1
years old at study entry and 83.7% were white. Approxi-
mately 11.1% were non-drinkers, 18.0% were past drinkers
and of the current drinkers, 47.4% preferred wine, 6.6% pre-
ferred beer, 12.7% preferred hard liquor, 15.7% had no
strong preference, and 17.7% drank infrequently. Strong as-
sociations between baseline characteristics and preference
of type of alcohol were observed. For example, 86.9% of
non-drinkers also reported never having smoked whereas
only 40.0% of the beer drinkers never smoked. In addition,
wine drinkers reported more physical activity than any
other category of alcohol preference. Only 1.3% of non-
drinkers experienced a hip fracture during the follow up
period, whereas percentages were even lower for all current
alcohol consumer types with the exception of hard liquor
drinkers (1.4%) and past consumers (1.2%) (Figure 2).
Consumption of alcohol was comparable across type
of preference and relatively low (mean: 3.34 servings per
Table 1 Baseline demographic and risk factor characteristics by alcohol type preference in the WHI OS+CT cohort
Covariate Drinker type classification Total χ2 p-value




Prefer wine Non-drinker Past drinker
Cohort 5405 4.7 10412 9.0 12876 11.1 14483 12.5 38841 33.6 12805 11.1 20833 18.0 115655
Characteristics at baseline
Ethnicity <.0001
American Indian or Alaskan
Native
29 33 42 53 100 78 116 451
0.5 0.3 0.3 0.4 0.3 0.6 0.6
Asian or Pacific Islander 104 66 141 482 581 1253 660 3287
1.9 0.6 1.1 3.3 1.5 9.8 3.2
Black or African-American 566 636 693 1256 1636 1702 3098 9587
10.5 6.1 5.4 8.7 4.2 13.3 14.9
Hispanic/Latino 370 190 400 588 955 829 980 4312
6.9 1.8 3.1 4.1 2.5 6.5 4.7
White (not of Hispanic origin) 4271 9407 11495 11923 35193 8741 15710 96740
79.0 90.4 89.3 82.3 90.6 68.3 75.4
Other 65 80 105 181 376 202 269 1278
1.2 0.8 0.8 1.3 1.0 1.6 1.3
Age group at screening <.0001
<50-59 2251 2819 4981 5467 13379 3523 6667 39087
41.4 27.1 38.7 37.8 34.5 27.5 32.0
60-69 2355 4917 5709 6324 17772 5896 9384 52357
43.6 47.2 44.3 43.7 45.8 46.0 45.0
70-79+ 799 2676 2186 2692 7690 3386 4782 24211
14.8 25.7 17.0 18.6 19.8 26.4 23.0
Education <.0001
High school or less 2038 3171 3234 5044 8858 5835 8625 36805
37.7 30.5 25.1 34.8 22.8 45.6 41.4
Some college/AA 1410 3040 3575 4306 10568 3009 5708 31616
26.1 29.2 27.8 29.7 27.2 23.5 27.4
College/post sec. 1957 4201 6067 5133 19415 3961 6500 47234
36.2 40.4 47.1 35.4 50.0 30.9 31.2
Osteoporosis <.0001
No 5104 9748 12148 13566 36291 11726 19075 107658
94.4 93.6 94.4 93.7 93.4 91.6 91.6
Yes 301 664 728 917 2550 1079 1758 7997
5.6 6.4 5.7 6.3 6.6 8.4 8.4
Number of falls in the past 12 months <.0001
None 3727 7256 8670 9962 26733 9013 14223 79584
69.0 69.7 67.3 68.8 68.8 70.4 68.3
1 time 1035 2009 2622 2830 7825 2340 3990 22651
19.2 19.3 20.4 19.5 20.2 18.3 19.2
2 times 425 804 1104 1166 2973 956 1682 9110
7.9 7.7 8.6 8.1 7.7 7.5 8.1
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Table 1 Baseline demographic and risk factor characteristics by alcohol type preference in the WHI OS+CT cohort
(Continued)
3 or more times 218 343 480 525 1310 496 938 4310
4.0 3.3 3.7 3.6 3.4 3.9 4.5
Prior hip fracture at baseline at age 55+ 0.0193
No 5391 10375 12849 14441 38723 12757 20744 115280
99.7 99.6 99.8 99.7 99.7 99.6 99.6
Yes 14 37 27 42 118 48 89 375
0.3 0.4 0.2 0.3 0.3 0.4 0.4
Parent had hip fracture at age 55+ <.0001
No 4763 8974 11148 12638 33545 11212 18303 100583
88.1 86.2 86.6 87.3 86.4 87.6 87.9
Yes 642 1438 1728 1845 5296 1593 2530 15072
11.9 13.8 13.4 12.7 13.6 12.4 12.1
On bisphosphonate medication at screening <.0001
No 5328 10228 12670 14290 38020 12540 20481 113557
98.6 98.2 98.4 98.7 97.9 97.9 98.3
Yes 77 184 206 193 821 265 352 2098
1.4 1.8 1.6 1.3 2.1 2.1 1.7
Amount of alcohol consumption NA
Servings per week 4.2 6.1 3.4 0 3.7 0 0 2.4
6.3 7.3 5.4 0.0 5.2 0.0 0.0 4.8
Category of alcohol consumption NA
Non-drinker 0 0 0 0 0 12805 0 12805
0.0 0.0 0.0 0.0 0.0 100.0 0.0
Past drinker 0 0 0 0 0 0 20833 20833
0.0 0.0 0.0 0.0 0.0 0.0 100.0
<1 drink per month 0 0 0 14483 0 0 0 14483
0.0 0.0 0.0 100.00 0.0 0.0 0.0
<1 drink per week 1832 2373 5504 0 14135 0 0 23844
33.9 22.8 42.8 0.0 36.4 0.0 0.0
1-<7 drinks per week 2580 4549 5702 0 17302 0 0 30133
47.7 43.7 44.3 0.0 44.6 0.0 0.0
7+ drinks per week 993 3490 1670 0 7404 0 0 13557
18.4 33.5 13.0 0.0 19.1 0.0 0.0
Smoking status <.0001
Never Smoked 2161 3677 5729 8225 18982 11129 9938 59841
40.0 35.3 44.5 56.8 48.9 86.9 47.7
Past Smoker 2623 5306 6284 5119 18011 1419 9370 48132
48.5 51.0 48.8 35.3 46.4 11.1 45.0
Current Smoker 621 1429 863 1139 1848 257 1525 7682
11.5 13.7 6.7 7.9 4.8 2.0 7.3
HT Use <.0001
Never used 2451 4466 5018 6543 14962 6319 9666 49425
45.4 42.9 39.0 45.2 38.5 49.4 46.4
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Table 1 Baseline demographic and risk factor characteristics by alcohol type preference in the WHI OS+CT cohort
(Continued)
Past user 790 1661 1839 2158 5609 1968 3489 17514
14.6 16.0 14.3 14.9 14.4 15.4 16.8
Current user 2164 4285 6019 5782 18270 4518 7678 48716
40.0 41.2 46.8 39.9 47.0 35.3 36.9
Physical activity <.0001
MET hours per week 12.2 12.6 13.9 10.6 14.7 10.1 10.9 12.6
14.1 13.5 14.0 12.5 14.3 12.6 13.5 13.8
BMI <.0001
Underweight 54 69 71 85 353 168 201 1001
1.0 0.7 0.6 0.6 0.9 1.3 1.0
Normal 1896 3711 4626 3989 16488 3965 5795 40470
35.1 35.6 35.9 27.5 42.5 31.0 27.8
Overweight 1869 3816 4710 4845 13814 4278 6817 40149
34.6 36.7 36.6 33.5 35.6 33.4 32.7
Obese I 1037 1797 2243 3256 5573 2603 4537 21046
19.2 17.3 17.4 22.5 14.4 20.3 21.8
Obese II 365 691 834 1455 2952 1134 2131 8541
6.8 6.6 6.5 10.1 4.7 8.9 10.2
Obese III 184 328 392 853 772 657 1352 4538
3.4 3.2 3.0 5.9 2.0 5.1 6.5
Incident hip fracture during follow up 0.0065
No 5344 10272 12749 14308 38459 12640 20593 114365
98.9 98.7 99.0 98.8 99.0 98.7 98.9
Yes 61 140 127 175 382 165 240 1290
1.1 1.3 1.0 1.2 1.0 1.3 1.2
Death during follow up <.0001
No 5127 9772 12357 13765 37194 12065 19323 109603
94.9 93.9 96.0 95.0 95.8 94.2 92.8
Yes 278 640 519 718 1647 740 1510 6052
5.1 6.2 4.0 5.0 4.2 5.8 7.3
Note: counts and percentages are presented for categorical variables; means and standard deviations are presented for continuous variables.
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consumption). Of those who prefer beer, average con-
sumption was half a medium serving per day; this was
also true for those who prefer wine. Those with a prefer-
ence for hard liquor consumed three-fourths of a medium
serving each day on average.
Preference of type of alcohol at baseline was strongly
associated with risk of hip fracture (p=0.0167). Preferring
wine was associated with 22% fewer hip fractures com-
pared to non-drinkers; no other category was significantly
different from non-drinkers. Further, wine drinkers experi-
enced a reduced risk of hip fracture compared to beer
drinkers (OR=0.72; 95% CI 0.55-0.95), hard liquor
drinkers (OR=0.87; 95% CI 0.71-1.06), those with no
strong preference (OR=0.89; 95% CI 0.73-1.10), infrequentdrinkers (OR=0.73; 95% CI 0.61-0.88), and past consumers
(OR=0.85; 95% CI 0.72-1.00). Asian, Black, and Hispanic
women had a lower risk of hip fracture compared to white
women; increasing age greatly increased the risk of hip
fracture. Other risk factors for hip fracture included hav-
ing osteoporosis, increasing number of falls in the past
year, lower BMI category, less physical activity, current
smoking, never using hormone therapy (HT), having a
previous hip fracture at age 55+, and having a parent who
fractured her or his hip at age 40+ (Table 2). When cat-
egories of current drinkers were combined, current
drinkers had a 12.2% lower risk of hip compared to non-
drinkers (p-value = 0.3510, not shown).
To evaluate whether specific types of alcohol con-
sumed (beer, wine or hard liquor) are associated with



















Figure 2 Percent of participants with incident hip fracture during the study period.
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Specifically, indicators for consuming at least one serv-
ing of beer per week, consuming at least one serving of
wine per week, and consuming at least one serving of
hard liquor per week were jointly included in the model.
Whereas no association was observed between beer con-
sumption or hard liquor consumption and risk of hip
fracture, a protective association was observed for wine,
where the odds ratio of 0.75 (95% CI 0.64-0.87) sug-
gested that wine drinkers have a 25% reduction in the
risk of hip fracture after adjusting for consumption of
other alcohol types and other confounders (Table 3).
To investigate the potential effect of amount of alcohol
consumed, total alcohol servings per week was explored
as a confounder both categorically and continuously. Total
amount consumed was not significantly associated with
hip fracture (category: p=0.6827, amount: p=0.8162), nor
did it affect the coefficients corresponding to alcohol pref-
erence. Due to the low consumption in this cohort, the
U-shaped relationship with hip fracture was not observed.
Age at menopause and dietary covariates for fruit,
vegetable, fiber and dairy consumption were not in-
cluded in the final models, as they did not change the
coefficients corresponding to the covariate of interest
and were not associated with hip fracture in exploratory
analyses. The number of falls in the past year was ex-
plored as a potential moderator. A test for an interaction
effect between falls and alcohol preference was not
rejected (p-value=0.5846), suggesting that falls do not
moderate the relationship between alcohol preference and
hip fracture. Falls were also explored as a potential medi-
ator; models fit with and without falls did not attenuate
the effect of alcohol preference or change the point esti-
mates for alcohol preference in a meaningful way. Add-
itionally, there was not sufficient evidence to suggest the
BMI modified the association between type of preferenceand hip fracture (p=0.7218). Interactions between prefer-
ence and education (p=0.2301) and preference and age
group (p=0.4120) were similarly not significant. We did
not find evidence of effect modification by study cohort
(CT and OS); further, when analyses were stratified by co-
hort, associations were in the same direction. Among the
participants in the OS, those who preferred white wine,
red wine, or both types had a lower risk of hip fracture
compared to non-drinkers, however, this association
was not significant (p=0.8731). In addition, indicators
for more than one serving of red wine per week and more
than one serving of white wine per week was not signifi-
cant (p=0.6246 and p=0.1124 respectively).
Sensitivity analyses
To assess the influence of women with a prior hip frac-
ture at baseline after age 55 on our findings, the analysis
was repeated after excluding these women. The associ-
ation of interest remained (p=0.0112, OR for wine prefer-
ence compared to non-drinkers = 0.76; 95% CI 0.62-0.92).
Results were similar for the second sensitivity analysis, in
which participants who reported having osteoporosis at
baseline were excluded (p=0.0071, OR for wine preference
compared to non-drinkers = 0.74; 95% CI 0.60-0.92).
When indicators for beer, wine and liquor consumption
were defined as more than 7 drinks per week in accord-
ance with the 2010 Dietary Guidelines for Americans
definition of moderate drinking, point estimates were in
the same direction as the analysis defining consumption
as more than 1 drink per week.
Discussion
We found compelling variation in risk of hip fracture by
type of alcohol preference, where women who preferred
wine appeared to have the lowest risk of hip fracture. In
an alternative model, where the association of each type of
Table 2 Associations between alcohol type preference and incident hip fracture in the WHI OS+CT cohort
Covariate Unadjusted model Adjusted model
Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value
Alcohol type preference p=0.0067 p=0.0167
Prefer beer vs. Non-drinker 0.87 (0.65, 1.18) 1.07 (0.79, 1.46)
Prefer liquor vs. Non-drinker 1.04 (0.83, 1.31) 0.90 (0.71, 1.14)
No strong preference vs. Non-drinker 0.76 (0.61, 0.96) 0.87 (0.68, 1.11)
Infrequent drinker vs. Non-drinker 0.94 (0.76, 1.16) 1.06 (0.85, 1.32)
Prefer wine vs. Non-drinker 0.76 (0.63, 0.91) 0.78 (0.64, 0.95)
Past drinker vs. Non-drinker 0.89 (0.73, 1.09) 0.92 (0.75, 1.13)
Ethnicity p<.0001
American Indian or Alaska Native vs. White 0.81 (0.30, 2.18)
Asian or Pacific Islander vs. White 0.32 (0.19, 0.53)
Black or African-American vs. White 0.32 (0.22, 0.46)
Hispanic or Latino vs. White 0.31 (0.17, 0.55)
Other vs. White 0.51 (0.25, 1.02)
Age group at screening p<.0001
60-69 vs. 50-59 2.78 (2.25, 3.45)
70-79 vs. 50-59 9.37 (7.59, 11.56)
Education p=0.8491
HS vs. College 1.04 (0.91, 1.19)
Some college vs. College 1.03 (0.90, 1.19)
Osteoporosis at screening p<.0001
No vs. Yes 0.58 (0.49, 0.68)
Falls in the past year p<.0001
1 vs. None 1.15 (1.00, 1.32)
2 vs. None 1.45 (1.20, 1.75)
3+ vs. None 2.13 (1.69, 2.68)
Previous hip fracture at age 55+ p=0.0005
No vs. Yes 0.45 (0.28, 0.70)
Parent had hip fracture at age 40+ p<.0001
No vs. Yes 0.68 (0.59, 0.78)
Bisphosphonate drug at screening p=0.1166
No vs. Yes 1.30 (0.94, 1.81)
Smoking status p=0.0053
Current vs. Never 1.42 (1.15, 1.77)
Past vs. Never 1.02 (0.91, 1.16)
Hormone therapy status p<.0001
Current vs. Never 0.65 (0.57, 0.74)
Past vs. Never 0.75 (0.64, 0.87)
Physical activity p<.0001
METs per week 0.99 (0.98, 0.99)
BMI Category p<.0001
Underweight vs. Normal 1.98 (1.37, 2.85)
Overweight vs. Normal 0.67 (0.58, 0.76)
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Table 2 Associations between alcohol type preference and incident hip fracture in the WHI OS+CT cohort (Continued)
Obese I vs. Normal 0.49 (0.41, 0.58)
Obese II vs. Normal 0.52 (0.40, 0.68)
Obese III vs. Normal 0.39 (0.25, 0.59)
Table 2 is adjusted for alcohol type preference, ethnicity, age group, education, osteoporosis, falls in the past year, bisphosphonate drug use, smoking status,
HT status, physical activity measured in MET hours, BMI category, HT trial arm, CaD trial arm, OS versus CT cohort, previous hip fracture at age 55+, and parental
history of hip fracture at age 40+.
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found that wine drinkers had a lower risk of hip fracture
relative to those who did not report consuming wine at
baseline.
We are not the first to investigate this question. In a
Danish cohort consisting of 31,785 participants, Høidrup
et al. found a significantly protective association with
wine preference in age-, sex- and study-adjusted models,
however the association did not persist after adjusting
for BMI, smoking, physical activity, and education [19].
While our conclusions are similar, our study also found
that the relationship between preferring wine com-
pared to non-drinking and hip fracture was significant
in a model adjusted for the same covariates and other
important predictors of hip fracture including falls in
the past year and history of hip fracture. Our results, how-
ever, are generalizable only to postmenopausal women
and our cohort on average reported less alcohol consump-
tion than the Danish cohort investigated by Høidrup.
Although their primary objective was assessing amount
of alcohol consumed, Mukamal et al. also examined beer,
wine, and liquor consumption in 5,865 participants in
the Cardiovascular Health Study. They included 0 (refer-
ence), <1, 1–6, and 7+ drinks per week categories for beer,
wine, and liquor and noted that no type was significantly
associated with hip fracture [20]. The HR for 1–6 drinks
per week of wine was 0.75 (95% CI 0.48-1.17), which is
similar to our finding that consumption of at least one
serving of wine per week is associated with a reduction in
risk of hip fracture of 25%.Table 3 Associations between consumption of beer, wine and
cohort
Logistic mode
Model HR (95% CI)
Consumes one or more servings of beer per week
Beer, yes vs. no 0.98 (0.75, 1.28)
Consumes one or more servings of liquor per week
Liquor, yes vs. no 1.37 (1.15, 1.63)
Consumes one or more servings of wine per week
Wine, yes vs. no 0.78 (0.67, 0.90)
Table 3 is adjusted for beer consumption, liquor consumption, wine consumption, e
bisphosphonate drug use, smoking status, HT status, physical activity measured in M
previous hip fracture at age 55+, and parental history of hip fracture at age 40+.Previous studies have suggested that moderate alcohol
consumption is protective in terms of hip fracture. For
example, although they did not distinguish between type
of alcohol consumed, Marrone et al. found a positive rela-
tionship between alcohol consumption and bone mineral
density (BMD) of the hip in a cohort of postmenopausal
women. They also found increased bone turnover in non-
drinkers compared to those who drank alcohol [34].
Our analysis suggests that much of the relationship
between alcohol and hip fracture may be due to wine
consumption. There are likely to be many unidentified dif-
ferences in individuals who prefer wine, beer or spirits.
Mortensen et al. identified some of these factors [35].
Because of the observational nature of this analysis we
can only speculate on the mechanisms of the associa-
tions we found. One possible explanation for this associ-
ation is the resveratrol content in wine. In a study of
bone loss in tail-suspended rats, resveratrol protected
against bone loss during immobilization [36]. Resveratrol
also acts as an inhibitor of adipogenesis and may poten-
tially promote osteoblast formation [37].
Hip and other osteoporotic fractures often result from
falls [2] and alcohol intake has been shown to influence
falls [20,22]. The J-shaped pattern observed between
amount of alcohol consumption and falls is similar to
that observed with hip fractures [38], suggesting that
falls may act as a mediator. We, however, found no evi-
dence of an interaction between falls in the past year at
baseline and alcohol preference on incident hip fracture;
this suggests that the association of alcohol preferenceliquor and incident hip fracture in the WHI CT+OS
l with alcohol consumption indicators







thnicity, age group, education, osteoporosis, falls in the past year,
ET hours, BMI category, HT trial arm, CaD trial arm, OS versus CT cohort,
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perienced falls. Furthermore, by comparing coefficients
for preference of type of alcohol in models with and
without an indicator for falling we examined whether
falling is a possible pathway by which alcohol may affect
hip fracture. As no attenuation of the association was
observed between models, there was not sufficient evi-
dence to indicate this as the case.
This analysis has a number of strengths; data are from
a large ethnically and racially diverse cohort of postmen-
opausal women and contained a large number of hip
fracture events. The outcome of interest, hip fracture,
was centrally adjudicated by the WHI Clinical Coordin-
ating Center. Further, the WHI collected many variables
of interest in assessing hip fracture risk including falls,
previous hip fractures, and family history of hip fracture
that have not been fully evaluated in previous research.
There are several limitations as well. Preference of al-
cohol type was defined at baseline for each participant
and does not capture lifetime consumption pattern,
however, data from follow up assessments of beer, wine
and hard liquor consumption suggest that preference
does not change greatly (Figure 3).
Further, we are unable to classify past drinkers by type
preference due to the lack of historical alcohol con-
sumption data. Information on past alcohol preference
would have allowed us to assess the effect of past prefer-
ences along with current preferences, which is of interest
as alcohol preference tends to differ greatly for younger
and older adults [39]. Also, preference of alcohol type
was assigned based on reported alcohol consumption
and on the food frequency questionnaire. However, in a
subset of women in the WHI, FFQs were compared with
four-day food records and 24-hour recalls; correlation
















Figure 3 Alcohol preference at baseline (entire cohort, CT+OS), year 1intake (four from recall, four from food records) was
0.86 for alcohol. The intra-class correlation coefficient
for test-retest reliability for alcohol was 0.92, suggesting
that for this cohort alcohol consumption is adequately
captured by FFQ [31].
Interestingly, total alcohol servings was explored as a
confounder and not found to alter results. A possible ex-
planation is that the overall variability for total alcohol
consumed was low. Lack of variability in total amount
consumed and low median alcohol intake in this cohort
may affect the generalizability of our results. Also, as the
FFQ did not ask participants the amounts of red and
white wine consumed, we were unable to differentiate
wine drinkers into red wine drinkers and white wine
drinkers except in the OS cohort.
Our analysis did not account for varying lengths of fol-
low up time. We also considered and fit Cox propor-
tional hazards models, using adjudicated time to hip
fracture and censored at the end of the main study,
death, or last follow up visit. Findings were comparable
based on this model. As hip fracture is a rare event (<2%
in the cohort during the study period) and follow-up
time is comparable among women across the levels of
the preference variable, our model choice of a logistic re-
gression was justified.
Unmeasured confounders of the relationship between
hip fracture and alcohol preference may exist. Although
we attempted to account for socio-demographic covariates
and dietary preferences by adjusting for education in the
model, wine drinkers may differ by other endogenous
characteristics or lifestyle factors that we did not observe.
Further, other socioeconomic characteristics such as in-
come [40,41], type of housing [40,42], living with someone
[43] or deprivation [44] might have been important con-
founders even after adjusting for education. TheseBaseline (CT+OS)
Year 1 (CT)
Year 3 (OS)
(CT only), and year 3 (OS only).
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especially with regards to wine [35]. Finally, not having
BMD measurements on this population limited us from
investigating the role of alcohol type on bone density, one
important mechanism to consider.
Conclusions
Postmenopausal women who are current alcohol con-
sumers and prefer wine experience significantly fewer
hip fractures compared to women who are non-drinkers,
as well as those who prefer beer, those who prefer liquor,
those with no strong preference, those who drink infre-
quently, and those who report being past alcohol con-
sumers. The variability in risk of hip fracture by type of
alcohol appears to be driven by the protective associ-
ation seen here for wine drinkers. Note that these results
generalize to a cohort of older women who are largely
light drinkers and may not apply to men or moderate to
heavy drinkers.
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